{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:33:59Z","timestamp":1790800439200,"version":"4.1.0"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T00:00:00Z","timestamp":1445990400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00281-015-0537-x","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T13:46:10Z","timestamp":1446039970000},"page":"167-183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":121,"title":["Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review"],"prefix":"10.1007","volume":"38","author":[{"given":"Dilara","family":"Kiran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan K.","family":"Podell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Basaraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,28]]},"reference":[{"issue":"1","key":"537_CR1","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/S2214-109X(14)70361-4","volume":"3","author":"A Zumla","year":"2015","unstructured":"Zumla A et al (2015) The WHO 2014 global tuberculosis report\u2014further to go. Lancet Glob Heal 3(1):e10\u2013e12","journal-title":"Lancet Glob Heal"},{"issue":"1","key":"537_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1749-6632.1968.tb16691.x","volume":"154","author":"G Canetti","year":"1968","unstructured":"Canetti G (1968) Biology of the mycobacterioses. Pathogenesis of tuberculosis in man. Ann N Y Acad Sci 154(1):13\u201318","journal-title":"Ann N Y Acad Sci"},{"issue":"2 Part 2","key":"537_CR3","first-page":"13","volume":"74","author":"G Canetti","year":"1956","unstructured":"Canetti G (1956) Dynamic aspects of the pathology and bacteriology of tuberculous lesions. Am Rev Tuberc 74(2 Part 2):13\u201321, discussion, 22\u20137","journal-title":"Am Rev Tuberc"},{"issue":"71","key":"537_CR4","doi-asserted-by":"crossref","first-page":"71ps6","DOI":"10.1126\/scitranslmed.3001847","volume":"3","author":"PT Elkington","year":"2011","unstructured":"Elkington PT, D\u2019Armiento JM, Friedland JS (2011) Tuberculosis immunopathology: the neglected role of extracellular matrix destruction. Sci Transl Med 3(71):71ps6","journal-title":"Sci Transl Med"},{"issue":"3 Pt 1","key":"537_CR5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.134.3.713","volume":"134","author":"JA Armstrong","year":"1971","unstructured":"Armstrong JA, Hart PD (1971) Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med 134(3 Pt 1):713\u2013740","journal-title":"J Exp Med"},{"issue":"6","key":"537_CR6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.smim.2014.09.009","volume":"26","author":"IM Orme","year":"2014","unstructured":"Orme IM, Basaraba RJ (2014) The formation of the granuloma in tuberculosis infection. Semin Immunol 26(6):601\u2013609","journal-title":"Semin Immunol"},{"issue":"1","key":"537_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tube.2013.07.004","volume":"94","author":"IM Orme","year":"2014","unstructured":"Orme IM (2014) A new unifying theory of the pathogenesis of tuberculosis. Tuberculosis (Edinb) 94(1):8\u201314","journal-title":"Tuberculosis (Edinb)"},{"key":"537_CR8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-4939-2450-9_11","volume":"1285","author":"CD Sohaskey","year":"2015","unstructured":"Sohaskey CD, Voskuil MI (2015) In vitro models that utilize hypoxia to induce non-replicating persistence in Mycobacteria. Methods Mol Biol 1285:201\u2013213","journal-title":"Methods Mol Biol"},{"issue":"6","key":"537_CR9","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/IAI.64.6.2062-2069.1996","volume":"64","author":"LG Wayne","year":"1996","unstructured":"Wayne LG, Hayes LG (1996) An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64(6):2062\u20132069","journal-title":"Infect Immun"},{"issue":"2","key":"537_CR10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s15010-009-8450-7","volume":"37","author":"S Ehlers","year":"2009","unstructured":"Ehlers S (2009) Lazy, dynamic or minimally recrudescent? On the elusive nature and location of the mycobacterium responsible for latent tuberculosis. Infection 37(2):87\u201395","journal-title":"Infection"},{"issue":"10","key":"537_CR11","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1074\/jbc.M112.445056","volume":"288","author":"W Lee","year":"2013","unstructured":"Lee W et al (2013) Intracellular Mycobacterium tuberculosis exploits host-derived fatty acids to limit metabolic stress. J Biol Chem 288(10):6788\u20136800","journal-title":"J Biol Chem"},{"issue":"6","key":"537_CR12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1242\/dmm.019570","volume":"8","author":"SM Irwin","year":"2015","unstructured":"Irwin SM et al (2015) Presence of multiple lesion types with vastly different microenvironments in C3HeB\/FeJ mice following aerosol infection with Mycobacterium tuberculosis. Dis Model Mech 8(6):591\u2013602","journal-title":"Dis Model Mech"},{"issue":"6","key":"537_CR13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1242\/dmm.019513","volume":"8","author":"JP Lanoix","year":"2015","unstructured":"Lanoix JP, Lenaerts AJ, Nuermberger EL (2015) Heterogeneous disease progression and treatment response in a C3HeB\/FeJ mouse model of tuberculosis. Dis Model Mech 8(6):603\u2013610","journal-title":"Dis Model Mech"},{"issue":"1","key":"537_CR14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/imr.12252","volume":"264","author":"A Lenaerts","year":"2015","unstructured":"Lenaerts A, Barry CE 3rd, Dartois V (2015) Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses. Immunol Rev 264(1):288\u2013307","journal-title":"Immunol Rev"},{"issue":"1","key":"537_CR15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/imr.12273","volume":"264","author":"MA Matty","year":"2015","unstructured":"Matty MA et al (2015) Adventures within the speckled band: heterogeneity, angiogenesis, and balanced inflammation in the tuberculous granuloma. Immunol Rev 264(1):276\u2013287","journal-title":"Immunol Rev"},{"issue":"3","key":"537_CR16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/2049-632X.12144","volume":"70","author":"DF Ackart","year":"2014","unstructured":"Ackart DF et al (2014) Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis. Pathog Dis 70(3):359\u2013369","journal-title":"Pathog Dis"},{"issue":"3","key":"537_CR17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/2049-632X.12143","volume":"70","author":"DF Ackart","year":"2014","unstructured":"Ackart DF et al (2014) Reversal of Mycobacterium tuberculosis phenotypic drug resistance by 2-aminoimidazole-based small molecules. Pathog Dis 70(3):370\u2013378","journal-title":"Pathog Dis"},{"issue":"7","key":"537_CR18","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1086\/605605","volume":"200","author":"Z Ahmad","year":"2009","unstructured":"Ahmad Z et al (2009) Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig. J Infect Dis 200(7):1136\u20131143","journal-title":"J Infect Dis"},{"issue":"5","key":"537_CR19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1164\/artpd.1959.79.5.684","volume":"79","author":"GJ Canetti","year":"1959","unstructured":"Canetti GJ (1959) Changes in tuberculosis as seen by a pathologist. Am Rev Tuberc 79(5):684\u2013686","journal-title":"Am Rev Tuberc"},{"issue":"1","key":"537_CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2008.12.032","volume":"136","author":"TD Bold","year":"2009","unstructured":"Bold TD, Ernst JD (2009) Who benefits from granulomas, mycobacteria or host? Cell 136(1):17\u201319","journal-title":"Cell"},{"issue":"1","key":"537_CR21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mib.2012.11.007","volume":"16","author":"DG Russell","year":"2013","unstructured":"Russell DG (2013) The evolutionary pressures that have molded Mycobacterium tuberculosis into an infectious adjuvant. Curr Opin Microbiol 16(1):78\u201384","journal-title":"Curr Opin Microbiol"},{"issue":"3","key":"537_CR22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/path.2055","volume":"210","author":"S Aly","year":"2006","unstructured":"Aly S et al (2006) Oxygen status of lung granulomas in Mycobacterium tuberculosis-infected mice. J Pathol 210(3):298\u2013305","journal-title":"J Pathol"},{"issue":"2","key":"537_CR23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0974-2727.86837","volume":"3","author":"K Patel","year":"2011","unstructured":"Patel K, Jhamb SS, Singh PP (2011) Models of latent tuberculosis: their salient features, limitations, and development. J Lab Physicians 3(2):75\u201379","journal-title":"J Lab Physicians"},{"issue":"13","key":"537_CR24","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/JB.184.13.3485-3491.2002","volume":"184","author":"I Rosenkrands","year":"2002","unstructured":"Rosenkrands I et al (2002) Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins. J Bacteriol 184(13):3485\u20133491","journal-title":"J Bacteriol"},{"issue":"2","key":"537_CR25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1462-5822.2005.00612.x","volume":"8","author":"MC Tsai","year":"2006","unstructured":"Tsai MC et al (2006) Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol 8(2):218\u2013232","journal-title":"Cell Microbiol"},{"issue":"6","key":"537_CR26","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/IAI.01515-07","volume":"76","author":"LE Via","year":"2008","unstructured":"Via LE et al (2008) Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 76(6):2333\u20132340","journal-title":"Infect Immun"},{"issue":"3","key":"537_CR27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/path.2185","volume":"212","author":"S Aly","year":"2007","unstructured":"Aly S et al (2007) Interferon-gamma-dependent mechanisms of mycobacteria-induced pulmonary immunopathology: the role of angiostasis and CXCR3-targeted chemokines for granuloma necrosis. J Pathol 212(3):295\u2013305","journal-title":"J Pathol"},{"issue":"5","key":"537_CR28","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI38482","volume":"119","author":"H Bruns","year":"2009","unstructured":"Bruns H et al (2009) Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J Clin Invest 119(5):1167\u20131177","journal-title":"J Clin Invest"},{"issue":"3","key":"537_CR29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.smim.2014.04.003","volume":"26","author":"A Dorhoi","year":"2014","unstructured":"Dorhoi A, Kaufmann SH (2014) Tumor necrosis factor alpha in mycobacterial infection. Semin Immunol 26(3):203\u2013209","journal-title":"Semin Immunol"},{"issue":"3","key":"537_CR30","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1128\/IAI.01011-07","volume":"76","author":"SD Chakravarty","year":"2008","unstructured":"Chakravarty SD et al (2008) Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs. Infect Immun 76(3):916\u2013926","journal-title":"Infect Immun"},{"issue":"Suppl 3","key":"537_CR31","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1086\/429994","volume":"41","author":"HM Algood","year":"2005","unstructured":"Algood HM, Lin PL, Flynn JL (2005) Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis 41(Suppl 3):S189\u2013S193","journal-title":"Clin Infect Dis"},{"issue":"1","key":"537_CR32","doi-asserted-by":"crossref","first-page":"e53657","DOI":"10.1371\/journal.pone.0053657","volume":"8","author":"N Kapoor","year":"2013","unstructured":"Kapoor N et al (2013) Human granuloma in vitro model, for TB dormancy and resuscitation. PLoS ONE 8(1):e53657","journal-title":"PLoS ONE"},{"issue":"12","key":"537_CR33","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1128\/IAI.68.12.6954-6961.2000","volume":"68","author":"LG Bekker","year":"2000","unstructured":"Bekker LG et al (2000) Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect Immun 68(12):6954\u20136961","journal-title":"Infect Immun"},{"issue":"Suppl 3","key":"537_CR34","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1093\/infdis\/jiu147","volume":"209","author":"S Nhamoyebonde","year":"2014","unstructured":"Nhamoyebonde S, Leslie A (2014) Biological differences between the sexes and susceptibility to tuberculosis. J Infect Dis 209(Suppl 3):S100\u2013S106","journal-title":"J Infect Dis"},{"issue":"1","key":"537_CR35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/imr.12259","volume":"264","author":"RT Robinson","year":"2015","unstructured":"Robinson RT, Orme IM, Cooper AM (2015) The onset of adaptive immunity in the mouse model of tuberculosis and the factors that compromise its expression. Immunol Rev 264(1):46\u201359","journal-title":"Immunol Rev"},{"issue":"6","key":"537_CR36","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1021\/mp200274r","volume":"8","author":"Q Zhang","year":"2011","unstructured":"Zhang Q et al (2011) The Goldilocks principle and antibiotic resistance in bacteria. Mol Pharm 8(6):2063\u20132068","journal-title":"Mol Pharm"},{"issue":"4","key":"537_CR37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.coph.2013.06.007","volume":"13","author":"DM Tobin","year":"2013","unstructured":"Tobin DM, Ramakrishnan L (2013) TB: the Yin and Yang of lipid mediators. Curr Opin Pharmacol 13(4):641\u2013645","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"537_CR38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.cell.2010.02.013","volume":"140","author":"DM Tobin","year":"2010","unstructured":"Tobin DM et al (2010) The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140(5):717\u2013730","journal-title":"Cell"},{"issue":"12","key":"537_CR39","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.1128\/IAI.73.12.8437-8441.2005","volume":"73","author":"H Cho","year":"2005","unstructured":"Cho H, McMurray DN (2005) Neutralization of tumor necrosis factor alpha suppresses antigen-specific type 1 cytokine responses and reverses the inhibition of mycobacterial survival in cocultures of immune guinea pig T lymphocytes and infected macrophages. Infect Immun 73(12):8437\u20138441","journal-title":"Infect Immun"},{"issue":"6\u20137","key":"537_CR40","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.micinf.2009.04.015","volume":"11","author":"LH Ly","year":"2009","unstructured":"Ly LH, Jeevan A, McMurray DN (2009) Neutralization of TNFalpha alters inflammation in guinea pig tuberculous pleuritis. Microbes Infect 11(6\u20137):680\u2013688","journal-title":"Microbes Infect"},{"issue":"6","key":"537_CR41","first-page":"432","volume":"47","author":"LH Ly","year":"2009","unstructured":"Ly LH, McMurray DN (2009) The Yin-Yang of TNFalpha in the guinea pig model of tuberculosis. Indian J Exp Biol 47(6):432\u2013439","journal-title":"Indian J Exp Biol"},{"issue":"1","key":"537_CR42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1124\/jpet.109.164970","volume":"334","author":"M Arai","year":"2010","unstructured":"Arai M et al (2010) Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. J Pharmacol Exp Ther 334(1):206\u2013213","journal-title":"J Pharmacol Exp Ther"},{"issue":"263","key":"537_CR43","doi-asserted-by":"crossref","first-page":"263ra159","DOI":"10.1126\/scitranslmed.3009885","volume":"6","author":"A Singhal","year":"2014","unstructured":"Singhal A et al (2014) Metformin as adjunct antituberculosis therapy. Sci Transl Med 6(263):263ra159","journal-title":"Sci Transl Med"},{"issue":"4","key":"537_CR44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nri3813","volume":"15","author":"RS Wallis","year":"2015","unstructured":"Wallis RS, Hafner R (2015) Advancing host-directed therapy for tuberculosis. Nat Rev Immunol 15(4):255\u2013263","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"537_CR45","first-page":"25","volume":"60","author":"P Morgenstern","year":"1949","unstructured":"Morgenstern P, Dewing SB (1949) Insulin in the treatment of tuberculous patients with anorexia; a modified technique. Am Rev Tuberc 60(1):25\u201331","journal-title":"Am Rev Tuberc"},{"issue":"5","key":"537_CR46","first-page":"481","volume":"69","author":"N Lewin","year":"1953","unstructured":"Lewin N, Aronovitch M (1953) Changing indications for collapse therapy in pulmonary tuberculosis. Can Med Assoc J 69(5):481\u2013486","journal-title":"Can Med Assoc J"},{"issue":"6","key":"537_CR47","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1378\/chest.89.6.822","volume":"89","author":"FG Schmid","year":"1986","unstructured":"Schmid FG, De Haller R (1986) Late exudative complications of collapse therapy for pulmonary tuberculosis. Chest 89(6):822\u2013827","journal-title":"Chest"},{"issue":"11","key":"537_CR48","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s002689900633","volume":"23","author":"AP Yim","year":"1999","unstructured":"Yim AP, Izzat MB, Lee TW (1999) Thoracoscopic surgery for pulmonary tuberculosis. World J Surg 23(11):1114\u20131117","journal-title":"World J Surg"},{"key":"537_CR49","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijid.2015.01.019","volume":"32","author":"R Madansein","year":"2015","unstructured":"Madansein R et al (2015) Surgical treatment of complications of pulmonary tuberculosis, including drug-resistant tuberculosis. Int J Infect Dis 32:61\u201367","journal-title":"Int J Infect Dis"},{"issue":"5","key":"537_CR50","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/1469-0691.12335","volume":"20","author":"KJ Seung","year":"2014","unstructured":"Seung KJ et al (2014) Salvage therapy for multidrug-resistant tuberculosis. Clin Microbiol Infect 20(5):441\u2013446","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"537_CR51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(12)70321-3","volume":"13","author":"JA Critchley","year":"2013","unstructured":"Critchley JA et al (2013) Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 13(3):223\u2013237","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"537_CR52","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0962-8479(93)90060-B","volume":"74","author":"AH Alzeer","year":"1993","unstructured":"Alzeer AH, FitzGerald JM (1993) Corticosteroids and tuberculosis: risks and use as adjunct therapy. Tuber Lung Dis 74(1):6\u201311","journal-title":"Tuber Lung Dis"},{"issue":"4","key":"537_CR53","first-page":"424","volume":"38","author":"JC Batten","year":"1957","unstructured":"Batten JC, Mc CR Jr (1957) The influence of corticotrophin and cortisone with antituberculous drugs on population of Mycobacterium tuberculosis in tissues of mice. Br J Exp Pathol 38(4):424\u2013437","journal-title":"Br J Exp Pathol"},{"issue":"4","key":"537_CR54","first-page":"413","volume":"38","author":"JC Batten","year":"1957","unstructured":"Batten JC, Mc CR Jr (1957) The influence of corticotrophin and certain corticosteroids on populations of Mycobacterium tuberculosis in tissues of mice. Br J Exp Pathol 38(4):413\u2013423","journal-title":"Br J Exp Pathol"},{"issue":"3","key":"537_CR55","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.tube.2015.02.039","volume":"95","author":"V Clifford","year":"2015","unstructured":"Clifford V et al (2015) The impact of anti-tuberculous antibiotics and corticosteroids on cytokine production in QuantiFERON-TB Gold In Tube assays. Tuberculosis (Edinb) 95(3):343\u2013349","journal-title":"Tuberculosis (Edinb)"},{"issue":"5","key":"537_CR56","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1164\/rccm.201007-1099OC","volume":"183","author":"P Brassard","year":"2011","unstructured":"Brassard P et al (2011) Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am J Respir Crit Care Med 183(5):675\u2013678","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"537_CR57","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/ijcp.12459","volume":"68","author":"WS Chung","year":"2014","unstructured":"Chung WS et al (2014) Inhaled corticosteroids and the increased risk of pulmonary tuberculosis: a population-based case\u2013control study. Int J Clin Pract 68(10):1193\u20131199","journal-title":"Int J Clin Pract"},{"key":"537_CR58","first-page":"192","volume":"49","author":"WR Barclay","year":"1953","unstructured":"Barclay WR et al (1953) Distribution of C14 labeled isoniazid in sensitive and resistant tubercle bacilli and in infected and uninfected tissues in tuberculous patients. Trans Annu Meet Natl Tuberc Assoc 49:192\u2013195","journal-title":"Trans Annu Meet Natl Tuberc Assoc"},{"issue":"16","key":"537_CR59","first-page":"1384","volume":"151","author":"WR Barclay","year":"1953","unstructured":"Barclay WR et al (1953) Distribution and excretion of radioactive isoniazid in tuberculous patients. J Am Med Assoc 151(16):1384\u20131388","journal-title":"J Am Med Assoc"},{"issue":"2","key":"537_CR60","first-page":"183","volume":"98","author":"RW Manthei","year":"1954","unstructured":"Manthei RW et al (1954) The distribution of C14 labeled isoniazid in normal and infected guinea pigs. Arch Int Pharmacodyn Ther 98(2):183\u2013192","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"537_CR61","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ijms.2014.08.024","volume":"377","author":"B Prideaux","year":"2015","unstructured":"Prideaux B et al (2015) Mass spectrometry imaging of levofloxacin distribution in TB-infected pulmonary lesions by MALDI-MSI and continuous liquid microjunction surface sampling. Int J Mass Spectrom 377:699\u2013708","journal-title":"Int J Mass Spectrom"},{"issue":"7","key":"537_CR62","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1128\/AAC.00115-15","volume":"59","author":"LE Via","year":"2015","unstructured":"Via LE et al (2015) A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosets. Antimicrob Agents Chemother 59(7):4181\u20134189","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"537_CR63","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/AAC.05208-11","volume":"56","author":"MC Kjellsson","year":"2012","unstructured":"Kjellsson MC et al (2012) Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions. Antimicrob Agents Chemother 56(1):446\u2013457","journal-title":"Antimicrob Agents Chemother"},{"key":"537_CR64","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jtbi.2014.11.021","volume":"367","author":"E Pienaar","year":"2015","unstructured":"Pienaar E et al (2015) A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment. J Theor Biol 367:166\u2013179","journal-title":"J Theor Biol"},{"issue":"3","key":"537_CR65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrmicro3200","volume":"12","author":"V Dartois","year":"2014","unstructured":"Dartois V (2014) The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells. Nat Rev Microbiol 12(3):159\u2013167","journal-title":"Nat Rev Microbiol"},{"issue":"6 Suppl 16","key":"537_CR66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/sonc.2002.37263","volume":"29","author":"J Folkman","year":"2002","unstructured":"Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29(6 Suppl 16):15\u201318","journal-title":"Semin Oncol"},{"issue":"3","key":"537_CR67","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thx.7.3.270","volume":"7","author":"L Cudkowicz","year":"1952","unstructured":"Cudkowicz L (1952) The blood supply of the lung in pulmonary tuberculosis. Thorax 7(3):270\u2013276","journal-title":"Thorax"},{"issue":"2","key":"537_CR68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0366-0869(52)80005-X","volume":"46","author":"L Cudkowicz","year":"1952","unstructured":"Cudkowicz L (1952) Some observations of the bronchial arteries in lobar pneumonia and pulmonary infarction. Br J Tuberc Dis Chest 46(2):99\u2013102","journal-title":"Br J Tuberc Dis Chest"},{"issue":"4","key":"537_CR69","first-page":"256","volume":"23","author":"CA Behling","year":"1993","unstructured":"Behling CA et al (1993) Induction of pulmonary granulomas, macrophage procoagulant activity, and tumor necrosis factor-alpha by trehalose glycolipids. Ann Clin Lab Sci 23(4):256\u2013266","journal-title":"Ann Clin Lab Sci"},{"issue":"4","key":"537_CR70","first-page":"371","volume":"36","author":"RL Hunter","year":"2006","unstructured":"Hunter RL et al (2006) Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann Clin Lab Sci 36(4):371\u2013386","journal-title":"Ann Clin Lab Sci"},{"issue":"Suppl","key":"537_CR71","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1472-9792(13)70003-9","volume":"93","author":"KJ Welsh","year":"2013","unstructured":"Welsh KJ, Hunter RL, Actor JK (2013) Trehalose 6,6\u2032-dimycolate\u2014a coat to regulate tuberculosis immunopathogenesis. Tuberculosis (Edinb) 93(Suppl):S3\u2013S9","journal-title":"Tuberculosis (Edinb)"},{"issue":"6","key":"537_CR72","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1378\/chest.125.6.2156","volume":"125","author":"F Alatas","year":"2004","unstructured":"Alatas F et al (2004) Vascular endothelial growth factor levels in active pulmonary tuberculosis. Chest 125(6):2156\u20132159","journal-title":"Chest"},{"issue":"3 Pt 1","key":"537_CR73","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1164\/ajrccm.162.3.9911010","volume":"162","author":"W Matsuyama","year":"2000","unstructured":"Matsuyama W et al (2000) Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis. Am J Respir Crit Care Med 162(3 Pt 1):1120\u20131122","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"537_CR74","doi-asserted-by":"crossref","first-page":"a018572","DOI":"10.1101\/cshperspect.a018572","volume":"5","author":"S Clark","year":"2015","unstructured":"Clark S, Hall Y, Williams A (2015) Animal models of tuberculosis: guinea pigs. Cold Spring Harb Perspect Med 5(5):a018572","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7536","key":"537_CR75","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature13967","volume":"517","author":"SH Oehlers","year":"2015","unstructured":"Oehlers SH et al (2015) Interception of host angiogenic signalling limits mycobacterial growth. Nature 517(7536):612\u2013615","journal-title":"Nature"},{"issue":"6","key":"537_CR76","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1073\/pnas.1424563112","volume":"112","author":"M Datta","year":"2015","unstructured":"Datta M et al (2015) Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery. Proc Natl Acad Sci U S A 112(6):1827\u20131832","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"537_CR77","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00408-011-9291-6","volume":"189","author":"TM Zielonka","year":"2011","unstructured":"Zielonka TM et al (2011) Angiogenic activity of sera from pulmonary tuberculosis patients in relation to IL-12p40 and TNFalpha serum levels. Lung 189(4):351\u2013357","journal-title":"Lung"},{"issue":"12","key":"537_CR78","first-page":"1324","volume":"9","author":"B Sloan","year":"2008","unstructured":"Sloan B, Scheinfeld NS (2008) Pazopanib, a VEGF receptor tyrosine kinase inhibitor for cancer therapy. Curr Opin Investig Drugs 9(12):1324\u20131335","journal-title":"Curr Opin Investig Drugs"},{"issue":"2","key":"537_CR79","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1378\/chest.112.2.440","volume":"112","author":"B Hirshberg","year":"1997","unstructured":"Hirshberg B et al (1997) Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest 112(2):440\u2013444","journal-title":"Chest"},{"issue":"2","key":"537_CR80","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1542\/peds.2011-3048","volume":"130","author":"PC Drobac","year":"2012","unstructured":"Drobac PC et al (2012) Risk factors for in-hospital mortality among children with tuberculosis: the 25-year experience in Peru. Pediatrics 130(2):e373\u2013e379","journal-title":"Pediatrics"},{"issue":"11","key":"537_CR81","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.5588\/ijtld.12.0848","volume":"17","author":"T Shimazaki","year":"2013","unstructured":"Shimazaki T et al (2013) Risk factors for death among hospitalised tuberculosis patients in poor urban areas in Manila, The Philippines. Int J Tuberc Lung Dis 17(11):1420\u20131426","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"537_CR82","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1159\/000050557","volume":"68","author":"Y Abe","year":"2001","unstructured":"Abe Y et al (2001) Serum levels of vascular endothelial growth factor and cavity formation in active pulmonary tuberculosis. Respiration 68(5):496\u2013500","journal-title":"Respiration"},{"issue":"4","key":"537_CR83","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/cpr.12193","volume":"48","author":"X Cun","year":"2015","unstructured":"Cun X et al (2015) Gene profile of soluble growth factors involved in angiogenesis, in an adipose-derived stromal cell\/endothelial cell co-culture, 3D gel model. Cell Prolif 48(4):405\u2013412","journal-title":"Cell Prolif"},{"issue":"9","key":"537_CR84","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.metabol.2013.04.010","volume":"62","author":"KN Aronis","year":"2013","unstructured":"Aronis KN, Chamberland JP, Mantzoros CS (2013) GLP-1 promotes angiogenesis in human endothelial cells in a dose-dependent manner, through the Akt, Src and PKC pathways. Metabolism 62(9):1279\u20131286","journal-title":"Metabolism"},{"issue":"1","key":"537_CR85","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1185\/030079907X253870","volume":"24","author":"DC Klonoff","year":"2008","unstructured":"Klonoff DC et al (2008) Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. Curr Med Res Opin 24(1):275\u2013286","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"537_CR86","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/joim.12016","volume":"273","author":"F Polet","year":"2013","unstructured":"Polet F, Feron O (2013) Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force. J Intern Med 273(2):156\u2013165","journal-title":"J Intern Med"},{"key":"537_CR87","doi-asserted-by":"crossref","unstructured":"Warner DF (2015) Mycobacterium tuberculosis metabolism. Cold Spring Harb Perspect Med. 5(4)","DOI":"10.1101\/cshperspect.a021121"},{"issue":"3","key":"537_CR88","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.tube.2013.02.008","volume":"93","author":"I Preez du","year":"2013","unstructured":"du Preez I, Loots DT (2013) New sputum metabolite markers implicating adaptations of the host to Mycobacterium tuberculosis, and vice versa. Tuberculosis (Edinb) 93(3):330\u2013337","journal-title":"Tuberculosis (Edinb)"},{"issue":"9","key":"537_CR89","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1021\/pr2003352","volume":"10","author":"BS Somashekar","year":"2011","unstructured":"Somashekar BS et al (2011) Metabolic profiling of lung granuloma in Mycobacterium tuberculosis infected guinea pigs: ex vivo 1H magic angle spinning NMR studies. J Proteome Res 10(9):4186\u20134195","journal-title":"J Proteome Res"},{"issue":"10","key":"537_CR90","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1021\/pr300345x","volume":"11","author":"BS Somashekar","year":"2012","unstructured":"Somashekar BS et al (2012) Metabolomic signatures in guinea pigs infected with epidemic-associated W-Beijing strains of Mycobacterium tuberculosis. J Proteome Res 11(10):4873\u20134884","journal-title":"J Proteome Res"},{"issue":"11","key":"537_CR91","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nri1710","volume":"5","author":"CJ Fox","year":"2005","unstructured":"Fox CJ, Hammerman PS, Thompson CB (2005) Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol 5(11):844\u2013852","journal-title":"Nat Rev Immunol"},{"key":"537_CR92","first-page":"358","volume":"5","author":"T Wang","year":"2014","unstructured":"Wang T, Liu G, Wang R (2014) The intercellular metabolic interplay between tumor and immune cells. Front Immunol 5:358","journal-title":"Front Immunol"},{"issue":"21","key":"537_CR93","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.4161\/cc.21804","volume":"11","author":"M MacFarlane","year":"2012","unstructured":"MacFarlane M, Robinson GL, Cain K (2012) Glucose\u2014a sweet way to die: metabolic switching modulates tumor cell death. Cell Cycle 11(21):3919\u20133925","journal-title":"Cell Cycle"},{"issue":"Pt 2","key":"537_CR94","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1042\/bj3270369","volume":"327","author":"N Ahmed","year":"1997","unstructured":"Ahmed N, Kansara M, Berridge MV (1997) Acute regulation of glucose transport in a monocyte-macrophage cell line: Glut-3 affinity for glucose is enhanced during the respiratory burst. Biochem J 327(Pt 2):369\u2013375","journal-title":"Biochem J"},{"issue":"8","key":"537_CR95","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/eji.1830080810","volume":"8","author":"JH Helderman","year":"1978","unstructured":"Helderman JH, Reynolds TC, Strom TB (1978) The insulin receptor as a universal marker of activated lymphocytes. Eur J Immunol 8(8):589\u2013595","journal-title":"Eur J Immunol"},{"issue":"1","key":"537_CR96","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/imr.12029","volume":"252","author":"J Barbi","year":"2013","unstructured":"Barbi J, Pardoll D, Pan F (2013) Metabolic control of the Treg\/Th17 axis. Immunol Rev 252(1):52\u201377","journal-title":"Immunol Rev"},{"issue":"7","key":"537_CR97","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.4049\/jimmunol.180.7.4476","volume":"180","author":"SR Jacobs","year":"2008","unstructured":"Jacobs SR et al (2008) Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol 180(7):4476\u20134486","journal-title":"J Immunol"},{"issue":"41","key":"537_CR98","doi-asserted-by":"crossref","first-page":"39337","DOI":"10.1074\/jbc.M305689200","volume":"278","author":"J Bentley","year":"2003","unstructured":"Bentley J et al (2003) Interleukin-3-mediated cell survival signals include phosphatidylinositol 3-kinase-dependent translocation of the glucose transporter GLUT1 to the cell surface. J Biol Chem 278(41):39337\u201339348","journal-title":"J Biol Chem"},{"issue":"1","key":"537_CR99","first-page":"30","volume":"2","author":"MM Delmastro-Greenwood","year":"2013","unstructured":"Delmastro-Greenwood MM, Piganelli JD (2013) Changing the energy of an immune response. Am J Clin Exp Immunol 2(1):30\u201354","journal-title":"Am J Clin Exp Immunol"},{"issue":"9","key":"537_CR100","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nri1685","volume":"5","author":"M Sitkovsky","year":"2005","unstructured":"Sitkovsky M, Lukashev D (2005) Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 5(9):712\u2013721","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"537_CR101","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1189\/jlb.0108024","volume":"84","author":"NJ Maciver","year":"2008","unstructured":"Maciver NJ et al (2008) Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 84(4):949\u2013957","journal-title":"J Leukoc Biol"},{"issue":"8","key":"537_CR102","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.4049\/jimmunol.1201538","volume":"189","author":"H Bruns","year":"2012","unstructured":"Bruns H et al (2012) Abelson tyrosine kinase controls phagosomal acidification required for killing of Mycobacterium tuberculosis in human macrophages. J Immunol 189(8):4069\u20134078","journal-title":"J Immunol"},{"issue":"5","key":"537_CR103","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chom.2011.09.010","volume":"10","author":"RJ Napier","year":"2011","unstructured":"Napier RJ et al (2011) Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis. Cell Host Microbe 10(5):475\u2013485","journal-title":"Cell Host Microbe"},{"issue":"3","key":"537_CR104","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","volume":"10","author":"I Pernicova","year":"2014","unstructured":"Pernicova I, Korbonits M (2014) Metformin\u2014mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol 10(3):143\u2013156","journal-title":"Nat Rev Endocrinol"},{"key":"537_CR105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12967-015-0443-y","volume":"13","author":"R Vashisht","year":"2015","unstructured":"Vashisht R, Brahmachari SK (2015) Metformin as a potential combination therapy with existing front-line antibiotics for tuberculosis. J Transl Med 13:83","journal-title":"J Transl Med"},{"issue":"11","key":"537_CR106","doi-asserted-by":"crossref","first-page":"e1000204","DOI":"10.1371\/journal.ppat.1000204","volume":"4","author":"P Peyron","year":"2008","unstructured":"Peyron P et al (2008) Foamy macrophages from tuberculous patients\u2019 granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog 4(11):e1000204","journal-title":"PLoS Pathog"},{"issue":"5","key":"537_CR107","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.chom.2012.09.012","volume":"12","author":"V Singh","year":"2012","unstructured":"Singh V et al (2012) Mycobacterium tuberculosis-driven targeted recalibration of macrophage lipid homeostasis promotes the foamy phenotype. Cell Host Microbe 12(5):669\u2013681","journal-title":"Cell Host Microbe"},{"issue":"7","key":"537_CR108","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/emmm.201000079","volume":"2","author":"MJ Kim","year":"2010","unstructured":"Kim MJ et al (2010) Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol Med 2(7):258\u2013274","journal-title":"EMBO Mol Med"},{"issue":"6","key":"537_CR109","doi-asserted-by":"crossref","first-page":"e1002093","DOI":"10.1371\/journal.ppat.1002093","volume":"7","author":"J Daniel","year":"2011","unstructured":"Daniel J et al (2011) Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog 7(6):e1002093","journal-title":"PLoS Pathog"},{"issue":"4","key":"537_CR110","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1371\/journal.pmed.0050075","volume":"5","author":"NJ Garton","year":"2008","unstructured":"Garton NJ et al (2008) Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med 5(4):e75","journal-title":"PLoS Med"},{"issue":"5","key":"537_CR111","doi-asserted-by":"crossref","first-page":"e1001065","DOI":"10.1371\/journal.pbio.1001065","volume":"9","author":"SH Baek","year":"2011","unstructured":"Baek SH, Li AH, Sassetti CM (2011) Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biol 9(5):e1001065","journal-title":"PLoS Biol"},{"issue":"1","key":"537_CR112","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/imr.12254","volume":"264","author":"S Tan","year":"2015","unstructured":"Tan S, Russell DG (2015) Trans-species communication in the Mycobacterium tuberculosis-infected macrophage. Immunol Rev 264(1):233\u2013248","journal-title":"Immunol Rev"},{"issue":"104","key":"537_CR113","doi-asserted-by":"crossref","first-page":"104ra102","DOI":"10.1126\/scitranslmed.3003045","volume":"3","author":"M Fabri","year":"2011","unstructured":"Fabri M et al (2011) Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med 3(104):104ra102","journal-title":"Sci Transl Med"},{"issue":"1","key":"537_CR114","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4049\/jimmunol.1400736","volume":"193","author":"H Salamon","year":"2014","unstructured":"Salamon H et al (2014) Cutting edge: vitamin D regulates lipid metabolism in Mycobacterium tuberculosis infection. J Immunol 193(1):30\u201334","journal-title":"J Immunol"},{"issue":"1","key":"537_CR115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nrmicro1065","volume":"3","author":"HI Boshoff","year":"2005","unstructured":"Boshoff HI, Barry CE 3rd (2005) Tuberculosis\u2014metabolism and respiration in the absence of growth. Nat Rev Microbiol 3(1):70\u201380","journal-title":"Nat Rev Microbiol"},{"issue":"21","key":"537_CR116","doi-asserted-by":"crossref","first-page":"9819","DOI":"10.1073\/pnas.1000715107","volume":"107","author":"J Marrero","year":"2010","unstructured":"Marrero J et al (2010) Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection. Proc Natl Acad Sci U S A 107(21):9819\u20139824","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"537_CR117","doi-asserted-by":"crossref","first-page":"e1002287","DOI":"10.1371\/journal.ppat.1002287","volume":"7","author":"S Watanabe","year":"2011","unstructured":"Watanabe S et al (2011) Fumarate reductase activity maintains an energized membrane in anaerobic Mycobacterium tuberculosis. PLoS Pathog 7(10):e1002287","journal-title":"PLoS Pathog"},{"issue":"16","key":"537_CR118","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1073\/pnas.1219375110","volume":"110","author":"H Eoh","year":"2013","unstructured":"Eoh H, Rhee KY (2013) Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 110(16):6554\u20136559","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"537_CR119","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nm1252","volume":"11","author":"EJ Munoz-Elias","year":"2005","unstructured":"Munoz-Elias EJ, McKinney JD (2005) Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med 11(6):638\u2013644","journal-title":"Nat Med"},{"issue":"19","key":"537_CR120","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1073\/pnas.1218599110","volume":"110","author":"A Michelucci","year":"2013","unstructured":"Michelucci A et al (2013) Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc Natl Acad Sci U S A 110(19):7820\u20137825","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"41","key":"537_CR121","doi-asserted-by":"crossref","first-page":"16386","DOI":"10.1021\/ja2070889","volume":"133","author":"CL Strelko","year":"2011","unstructured":"Strelko CL et al (2011) Itaconic acid is a mammalian metabolite induced during macrophage activation. J Am Chem Soc 133(41):16386\u201316389","journal-title":"J Am Chem Soc"},{"issue":"2","key":"537_CR122","doi-asserted-by":"crossref","first-page":"131","DOI":"10.33549\/physiolres.930430","volume":"53","author":"V Jakus","year":"2004","unstructured":"Jakus V, Rietbrock N (2004) Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res 53(2):131\u2013142","journal-title":"Physiol Res"},{"issue":"2","key":"537_CR123","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","volume":"44","author":"R Singh","year":"2001","unstructured":"Singh R et al (2001) Advanced glycation end-products: a review. Diabetologia 44(2):129\u2013146","journal-title":"Diabetologia"},{"issue":"8","key":"537_CR124","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/jcp.24920","volume":"230","author":"J Zhao","year":"2015","unstructured":"Zhao J et al (2015) Angiopoietin-1 protects the endothelial cells against advanced glycation end product injury by strengthening cell junctions and inhibiting cell apoptosis. J Cell Physiol 230(8):1895\u20131905","journal-title":"J Cell Physiol"},{"issue":"1\u20132","key":"537_CR125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.mce.2014.05.019","volume":"393","author":"F Shemirani","year":"2014","unstructured":"Shemirani F, Yazdanparast R (2014) The interplay between hyperglycemia-induced oxidative stress markers and the level of soluble receptor for advanced glycation end products (sRAGE) in K562 cells. Mol Cell Endocrinol 393(1\u20132):179\u2013186","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"537_CR126","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1476-5381.2009.00450.x","volume":"158","author":"C Liang","year":"2009","unstructured":"Liang C et al (2009) Rosiglitazone via upregulation of Akt\/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products. Br J Pharmacol 158(8):1865\u20131873","journal-title":"Br J Pharmacol"},{"issue":"4","key":"537_CR127","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3892\/etm.2014.1873","volume":"8","author":"B Yi","year":"2014","unstructured":"Yi B et al (2014) Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits hyperglycemia-induced apoptosis in myocytes by suppressing receptor for advanced glycation end products expression. Exp Ther Med 8(4):1185\u20131190","journal-title":"Exp Ther Med"},{"issue":"28","key":"537_CR128","doi-asserted-by":"crossref","first-page":"17810","DOI":"10.1074\/jbc.272.28.17810","volume":"272","author":"HM Lander","year":"1997","unstructured":"Lander HM et al (1997) Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272(28):17810\u201317814","journal-title":"J Biol Chem"},{"issue":"3","key":"537_CR129","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.arcmed.2007.11.013","volume":"39","author":"A Arce-Mendoza","year":"2008","unstructured":"Arce-Mendoza A et al (2008) Expression of CD64, CD206, and RAGE in adherent cells of diabetic patients infected with Mycobacterium tuberculosis. Arch Med Res 39(3):306\u2013311","journal-title":"Arch Med Res"},{"issue":"3\u20134","key":"537_CR130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.molimm.2012.05.014","volume":"52","author":"MA Zoelen van","year":"2012","unstructured":"van Zoelen MA et al (2012) Receptor for advanced glycation end products is protective during murine tuberculosis. Mol Immunol 52(3\u20134):183\u2013189","journal-title":"Mol Immunol"},{"issue":"10","key":"537_CR131","doi-asserted-by":"crossref","first-page":"e46824","DOI":"10.1371\/journal.pone.0046824","volume":"7","author":"BK Podell","year":"2012","unstructured":"Podell BK et al (2012) Non-diabetic hyperglycemia exacerbates disease severity in Mycobacterium tuberculosis infected guinea pigs. PLoS ONE 7(10):e46824","journal-title":"PLoS ONE"},{"key":"537_CR132","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1371\/journal.pone.0000029","volume":"1","author":"H Rachman","year":"2006","unstructured":"Rachman H et al (2006) Critical role of methylglyoxal and AGE in mycobacteria-induced macrophage apoptosis and activation. PLoS ONE 1:e29","journal-title":"PLoS ONE"},{"issue":"7","key":"537_CR133","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/hc0702.104183","volume":"105","author":"G Basta","year":"2002","unstructured":"Basta G et al (2002) Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105(7):816\u2013822","journal-title":"Circulation"},{"issue":"6","key":"537_CR134","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/cgt.2015.21","volume":"22","author":"BA Boone","year":"2015","unstructured":"Boone BA et al (2015) The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer. Cancer Gene Ther 22(6):326\u2013334","journal-title":"Cancer Gene Ther"},{"issue":"4","key":"537_CR135","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00281-013-0380-x","volume":"35","author":"S Hahn","year":"2013","unstructured":"Hahn S et al (2013) Modulation of neutrophil NETosis: interplay between infectious agents and underlying host physiology. Semin Immunopathol 35(4):439\u2013453","journal-title":"Semin Immunopathol"},{"issue":"6","key":"537_CR136","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1159\/000348676","volume":"5","author":"C Braian","year":"2013","unstructured":"Braian C, Hogea V, Stendahl O (2013) Mycobacterium tuberculosis-induced neutrophil extracellular traps activate human macrophages. J Innate Immunol 5(6):591\u2013602","journal-title":"J Innate Immunol"},{"issue":"1","key":"537_CR137","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tube.2008.09.009","volume":"89","author":"V Ramos-Kichik","year":"2009","unstructured":"Ramos-Kichik V et al (2009) Neutrophil extracellular traps are induced by Mycobacterium tuberculosis. Tuberculosis (Edinb) 89(1):29\u201337","journal-title":"Tuberculosis (Edinb)"},{"issue":"5","key":"537_CR138","first-page":"387","volume":"45","author":"Y Ishibashi","year":"2013","unstructured":"Ishibashi Y et al (2013) Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase. Horm Metab Res 45(5):387\u2013390","journal-title":"Horm Metab Res"},{"issue":"1","key":"537_CR139","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.diabres.2004.09.004","volume":"67","author":"N Ahmed","year":"2005","unstructured":"Ahmed N (2005) Advanced glycation endproducts\u2014role in pathology of diabetic complications. Diabetes Res Clin Pract 67(1):3\u201321","journal-title":"Diabetes Res Clin Pract"},{"issue":"23","key":"537_CR140","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1016\/j.tetlet.2015.01.122","volume":"56","author":"MA Richardson","year":"2015","unstructured":"Richardson MA et al (2015) Inhibition and breaking of advanced glycation end-products (AGEs) with bis-2-aminoimidazole derivatives. Tetrahedron Lett 56(23):3406\u20133409","journal-title":"Tetrahedron Lett"},{"issue":"3","key":"537_CR141","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/01480545.2011.614620","volume":"35","author":"SD Stowe","year":"2012","unstructured":"Stowe SD et al (2012) Evaluation of the toxicity of 2-aminoimidazole antibiofilm agents using both cellular and model organism systems. Drug Chem Toxicol 35(3):310\u2013315","journal-title":"Drug Chem Toxicol"},{"key":"537_CR142","doi-asserted-by":"crossref","unstructured":"Furlani RE et al. (2015) Second generation 2-aminoimidazole based advanced glycation end product inhibitors and breakers. Bioorg Med Chem Lett","DOI":"10.1016\/j.bmcl.2015.06.080"},{"issue":"3","key":"537_CR143","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.4432","volume":"235","author":"A Kubler","year":"2015","unstructured":"Kubler A et al (2015) Mycobacterium tuberculosis dysregulates MMP\/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation. J Pathol 235(3):431\u2013444","journal-title":"J Pathol"},{"issue":"1","key":"537_CR144","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/rccm.201311-2106PP","volume":"190","author":"CW Ong","year":"2014","unstructured":"Ong CW, Elkington PT, Friedland JS (2014) Tuberculosis, pulmonary cavitation, and matrix metalloproteinases. Am J Respir Crit Care Med 190(1):9\u201318","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"537_CR145","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","volume":"92","author":"R Visse","year":"2003","unstructured":"Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92(8):827\u2013839","journal-title":"Circ Res"},{"issue":"3","key":"537_CR146","doi-asserted-by":"crossref","first-page":"882","DOI":"10.4049\/jimmunol.1403110","volume":"195","author":"T Sathyamoorthy","year":"2015","unstructured":"Sathyamoorthy T et al (2015) Membrane type 1 matrix metalloproteinase regulates monocyte migration and collagen destruction in tuberculosis. J Immunol 195(3):882\u2013891","journal-title":"J Immunol"},{"issue":"1","key":"537_CR147","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/eji.201343593","volume":"44","author":"R Tadokera","year":"2014","unstructured":"Tadokera R et al (2014) Matrix metalloproteinases and tissue damage in HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur J Immunol 44(1):127\u2013136","journal-title":"Eur J Immunol"},{"issue":"5","key":"537_CR148","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1172\/JCI45666","volume":"121","author":"P Elkington","year":"2011","unstructured":"Elkington P et al (2011) MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Invest 121(5):1827\u20131833","journal-title":"J Clin Invest"},{"issue":"4","key":"537_CR149","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1165\/rcmb.2007-0011OC","volume":"37","author":"PT Elkington","year":"2007","unstructured":"Elkington PT et al (2007) Synergistic up-regulation of epithelial cell matrix metalloproteinase-9 secretion in tuberculosis. Am J Respir Cell Mol Biol 37(4):431\u2013437","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"7\u20138","key":"537_CR150","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.clinbiochem.2013.02.006","volume":"46","author":"C Xiong","year":"2013","unstructured":"Xiong C, Zhan X, Xiao Z (2013) Transcript levels of major MMPs and ADAMTS-4 in relation to the clinicopathological profile of patients with tuberculous intervertebral discs and healthy controls. Clin Biochem 46(7\u20138):603\u2013611","journal-title":"Clin Biochem"},{"issue":"10","key":"537_CR151","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.humimm.2012.07.042","volume":"73","author":"S Sundararajan","year":"2012","unstructured":"Sundararajan S, Babu S, Das SD (2012) Comparison of localized versus systemic levels of matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous pleuritis patients. Hum Immunol 73(10):985\u2013991","journal-title":"Hum Immunol"},{"issue":"3","key":"537_CR152","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/thx.2005.051979","volume":"61","author":"PT Elkington","year":"2006","unstructured":"Elkington PT, Friedland JS (2006) Matrix metalloproteinases in destructive pulmonary pathology. Thorax 61(3):259\u2013266","journal-title":"Thorax"},{"issue":"1","key":"537_CR153","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tube.2008.08.001","volume":"89","author":"SH Lee","year":"2009","unstructured":"Lee SH et al (2009) Effect of matrix metalloproteinase-9 -1562C\/T gene polymorphism on manifestations of pulmonary tuberculosis. Tuberculosis (Edinb) 89(1):68\u201370","journal-title":"Tuberculosis (Edinb)"},{"issue":"8","key":"537_CR154","first-page":"713","volume":"6","author":"E Hrabec","year":"2002","unstructured":"Hrabec E et al (2002) Circulation level of matrix metalloproteinase-9 is correlated with disease severity in tuberculosis patients. Int J Tuberc Lung Dis 6(8):713\u2013719","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"537_CR155","doi-asserted-by":"crossref","first-page":"e0117605","DOI":"10.1371\/journal.pone.0117605","volume":"10","author":"T Sathyamoorthy","year":"2015","unstructured":"Sathyamoorthy T et al (2015) Gender-dependent differences in plasma matrix metalloproteinase-8 elevated in pulmonary tuberculosis. PLoS ONE 10(1):e0117605","journal-title":"PLoS ONE"},{"issue":"5","key":"537_CR156","doi-asserted-by":"crossref","first-page":"e1004917","DOI":"10.1371\/journal.ppat.1004917","volume":"11","author":"CW Ong","year":"2015","unstructured":"Ong CW et al (2015) Neutrophil-derived MMP-8 drives AMPK-dependent matrix destruction in human pulmonary tuberculosis. PLoS Pathog 11(5):e1004917","journal-title":"PLoS Pathog"},{"issue":"9","key":"537_CR157","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1164\/rccm.201110-1769OC","volume":"185","author":"NF Walker","year":"2012","unstructured":"Walker NF et al (2012) Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases. Am J Respir Crit Care Med 185(9):989\u2013997","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"537_CR158","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1189\/jlb.0607338","volume":"82","author":"P Lint Van","year":"2007","unstructured":"Van Lint P, Libert C (2007) Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 82(6):1375\u20131381","journal-title":"J Leukoc Biol"},{"issue":"5","key":"537_CR159","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1440-1843.2007.01135.x","volume":"12","author":"M Seiscento","year":"2007","unstructured":"Seiscento M et al (2007) Transforming growth factor beta-1 as a predictor of fibrosis in tuberculous pleurisy. Respirology 12(5):660\u2013663","journal-title":"Respirology"},{"issue":"5","key":"537_CR160","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1462-5822.2006.00854.x","volume":"9","author":"LH Ly","year":"2007","unstructured":"Ly LH, Russell MI, McMurray DN (2007) Microdissection of the cytokine milieu of pulmonary granulomas from tuberculous guinea pigs. Cell Microbiol 9(5):1127\u20131136","journal-title":"Cell Microbiol"},{"issue":"1","key":"537_CR161","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-3083.2001.00844.x","volume":"53","author":"JO Olobo","year":"2001","unstructured":"Olobo JO et al (2001) Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts. Scand J Immunol 53(1):85\u201391","journal-title":"Scand J Immunol"},{"issue":"11","key":"537_CR162","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1128\/IAI.67.11.5730-5735.1999","volume":"67","author":"C Othieno","year":"1999","unstructured":"Othieno C et al (1999) Interaction of Mycobacterium tuberculosis-induced transforming growth factor beta1 and interleukin-10. Infect Immun 67(11):5730\u20135735","journal-title":"Infect Immun"},{"issue":"11","key":"537_CR163","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1590\/S1806-37132008001100009","volume":"34","author":"E Peresi","year":"2008","unstructured":"Peresi E et al (2008) Cytokines and acute phase serum proteins as markers of inflammatory regression during the treatment of pulmonary tuberculosis. J Bras Pneumol 34(11):942\u2013949","journal-title":"J Bras Pneumol"},{"issue":"6","key":"537_CR164","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/511277","volume":"195","author":"T Roberts","year":"2007","unstructured":"Roberts T et al (2007) Immunosuppression during active tuberculosis is characterized by decreased interferon-gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor-beta, and interleukin-4 mRNA levels. J Infect Dis 195(6):870\u2013878","journal-title":"J Infect Dis"},{"issue":"12","key":"537_CR165","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1128\/IAI.67.12.6461-6472.1999","volume":"67","author":"RE Rojas","year":"1999","unstructured":"Rojas RE et al (1999) Regulation of human CD4(+) alphabeta T-cell-receptor-positive (TCR(+)) and gammadelta TCR(+) T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor beta. Infect Immun 67(12):6461\u20136472","journal-title":"Infect Immun"},{"issue":"26","key":"537_CR166","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.2174\/1381612043383232","volume":"10","author":"H Tomioka","year":"2004","unstructured":"Tomioka H (2004) Adjunctive immunotherapy of mycobacterial infections. Curr Pharm Des 10(26):3297\u20133312","journal-title":"Curr Pharm Des"},{"issue":"6","key":"537_CR167","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.mehy.2009.04.037","volume":"73","author":"J Zhang","year":"2009","unstructured":"Zhang J et al (2009) Inhalation of TGF-beta1 antibody: a new method to inhibit the airway stenosis induced by the endobronchial tuberculosis. Med Hypotheses 73(6):1065\u20131066","journal-title":"Med Hypotheses"},{"issue":"12","key":"537_CR168","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1136\/thx.51.12.1253","volume":"51","author":"BG Marshall","year":"1996","unstructured":"Marshall BG et al (1996) Increased inflammatory cytokines and new collagen formation in cutaneous tuberculosis and sarcoidosis. Thorax 51(12):1253\u20131261","journal-title":"Thorax"},{"issue":"3","key":"537_CR169","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/sji.12136","volume":"79","author":"R Sivangala","year":"2014","unstructured":"Sivangala R et al (2014) Association of cytokine gene polymorphisms in patients with tuberculosis and their household contacts. Scand J Immunol 79(3):197\u2013205","journal-title":"Scand J Immunol"},{"issue":"6","key":"537_CR170","doi-asserted-by":"crossref","first-page":"510","DOI":"10.5588\/09640569513020","volume":"6","author":"T Niimi","year":"2002","unstructured":"Niimi T et al (2002) Transforming growth factor-beta gene polymorphism in sarcoidosis and tuberculosis patients. Int J Tuberc Lung Dis 6(6):510\u2013515","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"537_CR171","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1128\/IAI.72.3.1358-1363.2004","volume":"72","author":"SS Allen","year":"2004","unstructured":"Allen SS et al (2004) Effect of neutralizing transforming growth factor beta1 on the immune response against Mycobacterium tuberculosis in guinea pigs. Infect Immun 72(3):1358\u20131363","journal-title":"Infect Immun"},{"issue":"1","key":"537_CR172","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tube.2010.11.004","volume":"91","author":"AG Rosas-Taraco","year":"2011","unstructured":"Rosas-Taraco AG et al (2011) Local pulmonary immunotherapy with siRNA targeting TGFbeta1 enhances antimicrobial capacity in Mycobacterium tuberculosis infected mice. Tuberculosis (Edinb) 91(1):98\u2013106","journal-title":"Tuberculosis (Edinb)"},{"issue":"3","key":"537_CR173","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1189\/jlb.1208740","volume":"86","author":"HP Windish","year":"2009","unstructured":"Windish HP et al (2009) Aberrant TGF-beta signaling reduces T regulatory cells in ICAM-1-deficient mice, increasing the inflammatory response to Mycobacterium tuberculosis. J Leukoc Biol 86(3):713\u2013725","journal-title":"J Leukoc Biol"},{"issue":"6","key":"537_CR174","doi-asserted-by":"crossref","first-page":"e0126018","DOI":"10.1371\/journal.pone.0126018","volume":"10","author":"L Zheng","year":"2015","unstructured":"Zheng L et al (2015) Differential microRNA expression in human macrophages with Mycobacterium tuberculosis infection of Beijing\/W and non-Beijing\/W strain types. PLoS ONE 10(6):e0126018","journal-title":"PLoS ONE"},{"issue":"3\u20134","key":"537_CR175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0962-8479(97)90021-6","volume":"78","author":"G Vanham","year":"1997","unstructured":"Vanham G et al (1997) Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression\/anergy. Tuber Lung Dis 78(3\u20134):145\u2013158","journal-title":"Tuber Lung Dis"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-015-0537-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-015-0537-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-015-0537-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T17:20:51Z","timestamp":1692120051000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-015-0537-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,28]]},"references-count":175,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["537"],"URL":"https:\/\/doi.org\/10.1007\/s00281-015-0537-x","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,28]]}}}